Skip to main content
. 2024 Jul 17;16(14):2563. doi: 10.3390/cancers16142563

Table 4.

Total newly identified pathogenic/likely pathogenic (P/LP) variants.

Gene Variant Reference Sequence c Diagnosis Year Diagnosis Age
ATM p.M1? (c.3G>A) NM_000051.4 2006 65
APC a,b p.I1307K (c.3920T>A) NM_000038.6 2018 34
BARD1 b c.2300_2301delTG NM_000465.2 2013 61
BRCA1 c.3756_3759delGTCT NM_007294.4 2013 54
BRCA1 p.V1736A (c.5207T>C) NM_007294.4 2006 48
BRCA2 c.5073dupA NM_000059.4 2010 57
BRCA2 c.3847_3848delGT NM_000059.4 2011 60
CHEK2 p.H143Y (c.427C>T) NM_007194.4 2007 55
DICER1 p.R688* (c.2062C>T) NM_177438.3 2013 23
HOXB13 a,b p.G84E (c.251G>A) NM_006361.6 2007 47
MITF a,b p.E318K (c.952G>A) NM_000248.3 2007 51
MUTYH a,b p.G396D (c.1187G>A) NM_001128425.1 2006 49
MUTYH a,b p.G396D (c.1187G>A) NM_001128425.1 2013 68
PMS2 c.1040delA NM_000535.7 2013 52
RAD51D c.896_*505del761insT NM_002878.4 2006 83
SDHB a,b p.L111V (c.331C>G) NM_003000.3 2009 62

a Genetic test result not related to personal or family cancer history; b gene not historically associated with ovarian cancer risk; c matched annotation from the National Center for Biotechnology Information (NCBI) and European Molecular Biology Laboratory-European Bioinformatics Institute (EMBL-EBI) (MANE) reference sequence, version 1.3.